| Literature DB >> 35718419 |
John Alan Gambril1, Aaron Chum2, Akash Goyal3, Patrick Ruz2, Katarzyna Mikrut4, Orlando Simonetti5, Hardeep Dholiya6, Brijesh Patel7, Daniel Addison8.
Abstract
Cardiovascular (CV) events are an increasingly common limitation of effective anticancer therapy. Over the last decade imaging has become essential to patients receiving contemporary cancer therapy. Herein we discuss the current state of CV imaging in cardio-oncology. We also provide a practical apparatus for the use of imaging in everyday cardiovascular care of oncology patients to improve outcomes for those at risk for cardiotoxicity, or with established cardiovascular disease. Finally, we consider future directions in the field given the wave of new anticancer therapies.Entities:
Keywords: Advanced imaging; Cardiac MRI; Cardio-oncology; Echocardiography; Immunotherapy toxicity
Mesh:
Substances:
Year: 2022 PMID: 35718419 PMCID: PMC9280694 DOI: 10.1016/j.hfc.2022.02.007
Source DB: PubMed Journal: Heart Fail Clin ISSN: 1551-7136 Impact factor: 2.828